Novartis AG (NVS): Price and Financial Metrics

NVS POWR Grades

• Stability is the dimension where NVS ranks best; there it ranks ahead of 97.93% of US stocks.
• NVS's strongest trending metric is Quality; it's been moving up over the last 179 days.
• NVS ranks lowest in Momentum; there it ranks in the 8th percentile.

NVS Stock Summary

• NVS has a market capitalization of $195,579,594,849 -- more than approximately 98.87% of US stocks.
• In terms of twelve month growth in earnings before interest and taxes, Novartis Ag is reporting a growth rate of 150.75%; that's higher than 86.77% of US stocks.
• In terms of volatility of its share price, NVS is more volatile than only 8.5% of stocks we're observing.
• Stocks that are quantitatively similar to NVS, based on their financial statements, market capitalization, and price volatility, are BMY, NFLX, NVO, AMGN, and MRK.
• NVS's SEC filings can be seen here. And to visit Novartis Ag's official web site, go to www.novartis.com.

NVS Valuation Summary

• In comparison to the median Healthcare stock, NVS's price/sales ratio is 5.26% higher, now standing at 4.
• NVS's price/sales ratio has moved down 0.7 over the prior 243 months.
• Over the past 243 months, NVS's EV/EBIT ratio has gone up 1.9.

Below are key valuation metrics over time for NVS.

NVS Growth Metrics

Its 4 year price growth rate is now at 15.42%.
• The 5 year net income to common stockholders growth rate now stands at 78.85%.
• Its 5 year cash and equivalents growth rate is now at -10.97%.

Over the past 70 months, NVS's revenue has gone up $2,882,000,000.

The table below shows NVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	52,877	15,071	24,021
2021-09-30	52,385	15,192	9,807
2021-06-30	51,556	13,423	8,984
2021-03-31	49,884	13,252	7,955
2020-12-31	49,898	13,650	8,072
2020-09-30	49,584	13,185	7,103

NVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVS has a Quality Grade of B, ranking ahead of 86.01% of graded US stocks.
• NVS's asset turnover comes in at 0.42 -- ranking 108th of 682 Pharmaceutical Products stocks.
• GHSI, KALA, and ADAP are the stocks whose asset turnover ratios are most correlated with NVS.

The table below shows NVS's key quality metrics over time.